Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.

Hirschhorn T, Levi-Hofman M, Danziger O, Smorodinsky NI, Ehrlich M.

Cell Mol Life Sci. 2017 Jul;74(14):2645-2662. doi: 10.1007/s00018-017-2488-y. Epub 2017 Mar 29.

PMID:
28357470
2.

FIE, a nuclear PRC2 protein, forms cytoplasmic complexes in Arabidopsis thaliana.

Oliva M, Butenko Y, Hsieh TF, Hakim O, Katz A, Smorodinsky NI, Michaeli D, Fischer RL, Ohad N.

J Exp Bot. 2016 Nov;67(21):6111-6123. Epub 2016 Oct 17.

3.

MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.

Chalick M, Jacobi O, Pichinuk E, Garbar C, Bensussan A, Meeker A, Ziv R, Zehavi T, Smorodinsky NI, Hilkens J, Hanisch FG, Rubinstein DB, Wreschner DH.

PLoS One. 2016 Oct 21;11(10):e0165031. doi: 10.1371/journal.pone.0165031. eCollection 2016.

4.

Active immunization against vasoactive intestinal polypeptide decreases neuronal recruitment and inhibits reproduction in zebra finches.

Vistoropsky Y, Heiblum R, Smorodinsky NI, Barnea A.

J Comp Neurol. 2016 Aug 15;524(12):2516-28. doi: 10.1002/cne.23971. Epub 2016 Feb 15.

PMID:
26801210
5.

MUC1/SEC and MUC1/Y overexpression is associated with inflammation in Sjögren's syndrome.

Sung HH, Castro I, González S, Aguilera S, Smorodinsky NI, Quest A, Bahamondes V, Alliende C, Cortés J, Molina C, Urzúa U, Barrera MJ, Hermoso M, Herrera L, Leyton C, González MJ.

Oral Dis. 2015 Sep;21(6):730-8. doi: 10.1111/odi.12339. Epub 2015 Apr 6.

PMID:
25757505
6.

Constitutive negative regulation in the processing of the anti-Müllerian hormone receptor II.

Hirschhorn T, di Clemente N, Amsalem AR, Pepinsky RB, Picard JY, Smorodinsky NI, Cate RL, Ehrlich M.

J Cell Sci. 2015 Apr 1;128(7):1352-64. doi: 10.1242/jcs.160143. Epub 2015 Feb 6.

7.

Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β.

Shapira KE, Hirschhorn T, Barzilay L, Smorodinsky NI, Henis YI, Ehrlich M.

Mol Biol Cell. 2014 May;25(10):1620-8. doi: 10.1091/mbc.E13-09-0537. Epub 2014 Mar 19.

8.

Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy.

Kovjazin R, Horn G, Smorodinsky NI, Shapira MY, Carmon L.

PLoS One. 2014 Jan 8;9(1):e85400. doi: 10.1371/journal.pone.0085400. eCollection 2014.

9.

Epizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis.

Shai B, Schmukler E, Yaniv R, Ziv N, Horn G, Bumbarov V, Yadin H, Smorodinsky NI, Bacharach E, Pinkas-Kramarski R, Ehrlich M.

J Virol. 2013 Dec;87(24):13397-408. doi: 10.1128/JVI.02116-13. Epub 2013 Oct 2.

10.

Characterization of novel multiantigenic vaccine candidates with pan-HLA coverage against Mycobacterium tuberculosis.

Kovjazin R, Shitrit D, Preiss R, Haim I, Triezer L, Fuks L, Nader AR, Raz M, Bardenstein R, Horn G, Smorodinsky NI, Carmon L.

Clin Vaccine Immunol. 2013 Mar;20(3):328-40. doi: 10.1128/CVI.00586-12. Epub 2013 Jan 2.

11.

Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis.

Kovjazin R, Dubnik A, Horn G, Smorodinsky NI, Hardan I, Shapira MY, Carmon L.

Exp Ther Med. 2012 Jun;3(6):1092-1098. Epub 2012 Apr 3.

12.

Differential regulation of Smad3 and of the type II transforming growth factor-β receptor in mitosis: implications for signaling.

Hirschhorn T, Barizilay L, Smorodinsky NI, Ehrlich M.

PLoS One. 2012;7(8):e43459. doi: 10.1371/journal.pone.0043459. Epub 2012 Aug 22.

13.

Antibody targeting of cell-bound MUC1 SEA domain kills tumor cells.

Pichinuk E, Benhar I, Jacobi O, Chalik M, Weiss L, Ziv R, Sympson C, Karwa A, Smorodinsky NI, Rubinstein DB, Wreschner DH.

Cancer Res. 2012 Jul 1;72(13):3324-36. doi: 10.1158/0008-5472.CAN-12-0067. Epub 2012 Apr 16.

14.

Quantitative single cell monitoring of protein synthesis at subcellular resolution using fluorescently labeled tRNA.

Barhoom S, Kaur J, Cooperman BS, Smorodinsky NI, Smilansky Z, Ehrlich M, Elroy-Stein O.

Nucleic Acids Res. 2011 Oct;39(19):e129. doi: 10.1093/nar/gkr601. Epub 2011 Jul 27.

15.

ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors.

Kovjazin R, Volovitz I, Kundel Y, Rosenbaum E, Medalia G, Horn G, Smorodinsky NI, Brenner B, Carmon L.

Vaccine. 2011 Jun 24;29(29-30):4676-86. doi: 10.1016/j.vaccine.2011.04.103. Epub 2011 May 12.

PMID:
21570434
16.

Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks.

Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, Eppink B, Chung YM, Shalev G, Shema E, Shkedy D, Smorodinsky NI, van Vliet N, Kuster B, Mann M, Ciechanover A, Dahm-Daphi J, Kanaar R, Hu MC, Chen DJ, Oren M, Shiloh Y.

Mol Cell. 2011 Mar 4;41(5):529-42. doi: 10.1016/j.molcel.2011.02.015.

17.

Negative regulation of the endocytic adaptor disabled-2 (Dab2) in mitosis.

Chetrit D, Barzilay L, Horn G, Bielik T, Smorodinsky NI, Ehrlich M.

J Biol Chem. 2011 Feb 18;286(7):5392-403. doi: 10.1074/jbc.M110.161851. Epub 2010 Nov 19.

18.

ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1.

Horn G, Gaziel A, Wreschner DH, Smorodinsky NI, Ehrlich M.

Exp Cell Res. 2009 May 1;315(8):1490-504. doi: 10.1016/j.yexcr.2009.02.011. Epub 2009 Feb 23.

PMID:
19245809
19.

The MUC1 oncoprotein as a functional target: immunotoxin binding to alpha/beta junction mediates cell killing.

Rubinstein DB, Karmely M, Pichinuk E, Ziv R, Benhar I, Feng N, Smorodinsky NI, Wreschner DH.

Int J Cancer. 2009 Jan 1;124(1):46-54. doi: 10.1002/ijc.23910.

20.

Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.

Ziv S, Brenner O, Amariglio N, Smorodinsky NI, Galron R, Carrion DV, Zhang W, Sharma GG, Pandita RK, Agarwal M, Elkon R, Katzin N, Bar-Am I, Pandita TK, Kucherlapati R, Rechavi G, Shiloh Y, Barzilai A.

Hum Mol Genet. 2005 Oct 1;14(19):2929-43. Epub 2005 Sep 8.

PMID:
16150740
21.

The MUC1 SEA module is a self-cleaving domain.

Levitin F, Stern O, Weiss M, Gil-Henn C, Ziv R, Prokocimer Z, Smorodinsky NI, Rubinstein DB, Wreschner DH.

J Biol Chem. 2005 Sep 30;280(39):33374-86. Epub 2005 Jun 29.

22.

Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.

Zipin A, Israeli-Amit M, Meshel T, Sagi-Assif O, Yron I, Lifshitz V, Bacharach E, Smorodinsky NI, Many A, Czernilofsky PA, Morton DL, Witz IP.

Cancer Res. 2004 Sep 15;64(18):6571-8. Erratum in: Cancer Res. 2004 Nov 1;64(21):8130.

23.

Up-regulation of semaphorin expression in retina of glaucomatous rabbits.

Solomon AS, Kimron M, Holdengreber V, Nizan A, Yaakobowicz M, Harness E, Smorodinsky NI, Shirvan A, Barzilai A.

Graefes Arch Clin Exp Ophthalmol. 2003 Aug;241(8):673-81. Epub 2003 Jun 21.

PMID:
12827374
24.

Transmembrane and truncated (SEC) isoforms of MUC1 in the human endometrium and Fallopian tube.

Hey NA, Meseguer M, Simón C, Smorodinsky NI, Wreschner DH, Ortíz ME, Aplin JD.

Reprod Biol Endocrinol. 2003 Jan 30;1:2.

25.

ATM-dependent activation of the gene encoding MAP kinase phosphatase 5 by radiomimetic DNA damage.

Bar-Shira A, Rashi-Elkeles S, Zlochover L, Moyal L, Smorodinsky NI, Seger R, Shiloh Y.

Oncogene. 2002 Jan 24;21(5):849-55.

26.

Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis.

Ben-Arieh SV, Zimerman B, Smorodinsky NI, Yaacubovicz M, Schechter C, Bacik I, Gibbs J, Bennink JR, Yewdell JW, Coligan JE, Firat H, Lemonnier F, Ehrlich R.

J Virol. 2001 Nov;75(21):10557-62.

27.

Uniquely conserved non-translated regions are involved in generation of the two major transcripts of protein phosphatase 2Cbeta.

Seroussi E, Shani N, Ben-Meir D, Chajut A, Divinski I, Faier S, Gery S, Karby S, Kariv-Inbal Z, Sella O, Smorodinsky NI, Lavi S.

J Mol Biol. 2001 Sep 21;312(3):439-51.

PMID:
11563908
28.
29.

Protein phosphatase 2Calpha expression in normal human tissues: an immunohistochemical study.

Lifschitz-Mercer B, Sheinin Y, Ben-Meir D, Bramante-Schreiber L, Leider-Trejo L, Karby S, Smorodinsky NI, Lavi S.

Histochem Cell Biol. 2001 Jul;116(1):31-9.

PMID:
11479720
30.

Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype.

Spring K, Cross S, Li C, Watters D, Ben-Senior L, Waring P, Ahangari F, Lu SL, Chen P, Misko I, Paterson C, Kay G, Smorodinsky NI, Shiloh Y, Lavin MF.

Cancer Res. 2001 Jun 1;61(11):4561-8.

31.

The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells.

Eshel R, Zanin A, Sagi-Assif O, Meshel T, Smorodinsky NI, Dwir O, Alon R, Brakenhoff R, van Dongen G, Witz IP.

J Biol Chem. 2000 Apr 28;275(17):12833-40.

32.

MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.

Hartman M, Baruch A, Ron I, Aderet Y, Yoeli M, Sagi-Assif O, Greenstein S, Stadler Y, Weiss M, Harness E, Yaakubovits M, Keydar I, Smorodinsky NI, Wreschner DH.

Int J Cancer. 1999 Jul 19;82(2):256-67.

33.

The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein.

Baruch A, Hartmann M, Yoeli M, Adereth Y, Greenstein S, Stadler Y, Skornik Y, Zaretsky J, Smorodinsky NI, Keydar I, Wreschner DH.

Cancer Res. 1999 Apr 1;59(7):1552-61.

34.

Inhibition of the hydrolytic and transpeptidase activities of rat kidney gamma-glutamyl transpeptidase by specific monoclonal antibodies.

Bluvshtein E, Glass GA, Volohonsky G, Yaakubowitz M, Harness E, Smorodinsky NI, Seidel A, Frank H, Steinberg P, Stark AA.

Eur J Biochem. 1999 Mar;260(3):844-54.

35.

Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y.

Science. 1998 Sep 11;281(5383):1674-7.

36.

Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress.

Treister A, Sagi-Assif O, Meer M, Smorodinsky NI, Anavi R, Golan I, Meshel T, Kahana O, Eshel R, Katz BZ, Shevach E, Witz IP.

Int J Cancer. 1998 Jul 17;77(2):306-13.

37.

Humoral immune response to immunocomplexed HIV envelope glycoprotein 120.

Denisova G, Stern B, Raviv D, Zwickel J, Smorodinsky NI, Gershoni JM.

AIDS Res Hum Retroviruses. 1996 Jul 1;12(10):901-9.

PMID:
8798975
38.

Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice.

Emanuel N, Kedar E, Bolotin EM, Smorodinsky NI, Barenholz Y.

Pharm Res. 1996 Jun;13(6):861-8.

PMID:
8792423
39.

Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomes.

Emanuel N, Kedar E, Bolotin EM, Smorodinsky NI, Barenholz Y.

Pharm Res. 1996 Mar;13(3):352-9.

PMID:
8692725
40.

Vaccination against breast cancer--studies in an animal model.

Smorodinsky NI, Yarden R, Carmon L, Hareuveni M, Wreschner DH, Keydar I.

Adv Exp Med Biol. 1994;353:125-37. No abstract available.

PMID:
7985531
41.

HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex.

Gershoni JM, Denisova G, Raviv D, Smorodinsky NI, Buyaner D.

FASEB J. 1993 Sep;7(12):1185-7.

PMID:
7690724
42.

Neutralizing monoclonal antibodies against alpha and beta subunits of the Ustilago maydis virus encoded toxin.

Ginzberg I, Rosenblum S, Koltin Y, Smorodinsky NI.

Virus Genes. 1992 Aug;6(3):273-80.

PMID:
1413542
43.

Phenotypic properties of 3T3 cells transformed in vitro with polyoma virus and passaged once in syngeneic animals.

Langer AB, Emmanuel N, Even J, Fridman WH, Gohar O, Gonen B, Katz BZ, Ran M, Smorodinsky NI, Witz IP.

Immunobiology. 1992 Aug;185(2-4):281-91.

PMID:
1333442
44.

Autoantibody-mediated regulation of tumor growth.

Cahalon L, Korem S, Gonen B, Puri J, Smorodinsky NI, Witz IP.

Ann N Y Acad Sci. 1992 May 4;651:393-408. No abstract available.

PMID:
1376057
45.

Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies.

Dion AS, Smorodinsky NI, Williams CJ, Wreschner DH, Major PP, Keydar I.

Hybridoma. 1991 Oct;10(5):595-610.

PMID:
1804772
46.

Adherence pili of avian strains of Escherichia coli O78.

Yerushalmi Z, Smorodinsky NI, Naveh MW, Ron EZ.

Infect Immun. 1990 Apr;58(4):1129-31.

47.

[Anti-idiotypes against human monoclonal antibodies which recognize breast cancer associated antigens].

Gendler Y, Smorodinsky NI.

Harefuah. 1990 Mar 1;118(5):279-81. Review. Hebrew. No abstract available.

PMID:
2188885
48.

Use of monoclonal antibodies in the purification of an inhibitor of virus replication by affinity chromatography.

Gera A, Sadka A, Spiegel S, Salomon R, Smorodinsky NI.

J Gen Virol. 1989 May;70 ( Pt 5):1293-6.

PMID:
2732715
49.

Bearing certain tumors may result in autoimmunity.

Witz IP, Cahalon L, Smorodinsky NI, Ran M.

Isr J Med Sci. 1988 Dec;24(12):744-6. No abstract available.

PMID:
2465285
50.

Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.

Smorodinsky NI, Ghendler Y, Bakimer R, Chaitchuk S, Keydar I, Shoenfeld Y.

Eur J Immunol. 1988 Nov;18(11):1713-8.

PMID:
2849550

Supplemental Content

Loading ...
Support Center